AI filing briefs · archive

8-K filings in July 2026, explained

1,916 material Form 8-K filings that 1,609 companies we cover made with the SEC in July 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).

2 of 1,916 briefs match

newest first · times in ET

MSTRStrategy Inc Jul 6, 8:00 AM ET

Strategy reports $8.32 billion Q2 digital asset loss and sells some bitcoin

Negative earnings Written later 5.02 7.01 8.01

Strategy disclosed an $8.32 billion loss on digital assets for the quarter ended June 30, 2026, almost all of it unrealized, and said its bitcoin cost basis exceeded fair value at quarter-end. It also sold bitcoin to fund preferred stock distributions and replenish its USD Reserve, and named CFO Andrew Kang as principal accounting officer after the retirement of its chief accounting officer.

Q2 2026 loss on digital assets: $8.32 billion, including $8.31 billion unrealized and $0.9 million realized
Bitcoin sold: 1,363 BTC (June 29-30, $80.8 million) and 2,225 BTC (July 1-5, $135.2 million), with proceeds used for preferred stock distributions and the USD Reserve
Holdings fell to 843,775 BTC as of July 5, 2026; USD Reserve balance was $2.55 billion
Andrew Kang designated principal accounting officer effective June 30, 2026, after Jeanine Montgomery retired

Read the filing on SEC.gov ↗

REGNREGENERON PHARMACEUTICALS, INC. Jul 6, 7:00 AM ET

Regeneron expects $127 million Q2 2026 acquired IPR&D charge, a $1.00 per-share hit

Negative earnings Written later 2.02

Regeneron said its second quarter 2026 results will include an acquired in-process research and development (IPR&D) charge of about $127 million pre-tax, tied to up-front and opt-in payments under collaboration and licensing agreements. The company expects the charge to reduce both GAAP and non-GAAP net income per diluted share by about $1.00 for the quarter. The figures are preliminary and unaudited, and the company does not forecast such charges.

Expected acquired IPR&D charge of about $127 million on a pre-tax basis for Q2 2026
Expected impact of about $1.00 per diluted share on both GAAP and non-GAAP net income
Charge relates to up-front and opt-in payments under collaboration and licensing agreements
Q2 2026 results have not been finalized and remain subject to closing procedures

Read the filing on SEC.gov ↗

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.

Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.